{"transactions":[{"id":4019612,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":168734,"kind":"person","name":"Suzdak Peter David","position":1,"cik":"0001296629","reported_name":"Suzdak Peter David","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T16:26:34.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 20, 2017, the reporting person was granted 25,000 RSUs, of which 6,250 vested on February 28, 2018.  The remaining RSUs will vest in three equal annual installments on the last business day in February, beginning February 28, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 20, 2017, the reporting person was granted 25,000 RSUs, of which 6,250 vested on February 28, 2018.  The remaining RSUs will vest in three equal annual installments on the last business day in February, beginning February 28, 2019."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001140361-18-011646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296629/000114036118011646/form4.xml","form_type":"4"}},{"id":4019611,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":168734,"kind":"person","name":"Suzdak Peter David","position":1,"cik":"0001296629","reported_name":"Suzdak Peter David","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-02T16:26:34.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22250,"source":{"system":"sec-edgar","filing":"0001140361-18-011646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296629/000114036118011646/form4.xml","form_type":"4"}},{"id":4084727,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":168734,"kind":"person","name":"Suzdak Peter David","position":1,"cik":"0001296629","reported_name":"Suzdak Peter David","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-30T16:39:11.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":112271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the option vests and becomes exercisable on January 26, 2019, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested."}],"balance_after":112271,"derivative":{"exercise_price":2.29,"expiration_date":"2028-01-26","underlying":"Common Stock","underlying_shares":112271},"source":{"system":"sec-edgar","filing":"0001140361-18-003900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296629/000114036118003900/form4.xml","form_type":"4"}},{"id":4232245,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":168734,"kind":"person","name":"Suzdak Peter David","position":1,"cik":"0001296629","reported_name":"Suzdak Peter David","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-16T16:05:28.000Z","date":"2017-08-16","kind":"grant","acquired":true,"shares":10000,"price":1.9872,"value":19872.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $1.9872 per share represents a weighted average of purchase prices ranging from $1.96 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001140361-17-032420","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296629/000114036117032420/form4.xml","form_type":"4"}},{"id":4482888,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":168734,"kind":"person","name":"Suzdak Peter David","position":1,"cik":"0001296629","reported_name":"Suzdak Peter David","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-24T17:50:17.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001140361-17-002736","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296629/000114036117002736/form4.xml","form_type":"4"}},{"id":4482887,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":168734,"kind":"person","name":"Suzdak Peter David","position":1,"cik":"0001296629","reported_name":"Suzdak Peter David","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-24T17:50:17.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":1175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the option vests and becomes exercisable on January 20, 2018, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested."}],"balance_after":1175000,"derivative":{"exercise_price":0.184,"expiration_date":"2027-01-20","underlying":"Common Stock","underlying_shares":1175000},"source":{"system":"sec-edgar","filing":"0001140361-17-002736","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296629/000114036117002736/form4.xml","form_type":"4"}}]}